Affiliation:
1. Department of Gastroenterology, Peking University Third Hospital , Beijing 100191 , China
2. Beijing Key Laboratory for Helicobacter Pylori Infection and Upper Gastrointestinal Diseases , Beijing 100191 , China
Abstract
Abstract
Abnormal brain–gut interaction is considered the core pathological mechanism behind the disorders of gut–brain interaction (DGBI), in which the intestinal microbiota plays an important role. Microglia are the “sentinels” of the central nervous system (CNS), which participate in tissue damage caused by traumatic brain injury, resist central infection and participate in neurogenesis, and are involved in the occurrence of various neurological diseases. With in-depth research on DGBI, we could find an interaction between the intestinal microbiota and microglia and that they are jointly involved in the occurrence of DGBI, especially in individuals with comorbidities of mental disorders, such as irritable bowel syndrome (IBS). This bidirectional regulation of microbiota and microglia provides a new direction for the treatment of DGBI. In this review, we focus on the role and underlying mechanism of the interaction between gut microbiota and microglia in DGBI, especially IBS, and the corresponding clinical application prospects and highlight its potential to treat DGBI in individuals with psychiatric comorbidities.
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Publisher
Oxford University Press (OUP)
Subject
Cell Biology,Drug Discovery,Biochemistry,Biotechnology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献